Delivery Order SPE2DB20D2104-SPE2DB25FNABT
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Humalog 100 Unit/mL KwikPen 3mL insulin pens, with a ceiling value of $1,048.07. This is a firm fixed-price delivery order with an ultimate completion date of August 12, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation. This delivery order is...
- The Defense Logistics Agency awarded a $1,069.96 delivery order to AmerisourceBergen Drug Corp for Humalog 100 Unit/ML KwikPen 3ML insulin pens, with an ultimate completion date of July 22, 2025. This is a firm fixed price delivery order with no set-aside designation, issued competitively under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The product will be performed at AmerisourceBergen's Conshohocken, Pennsylvania location, where the company...
- The Defense Logistics Agency awarded a $12,366.42 delivery order to AmerisourceBergen Drug Corp for Humalog 100 Unit/ML KwikPen 3ML insulin pens, with an ultimate completion date of September 3, 2025. This competitive award, issued on September 2, 2025, carries no set-aside designation and utilizes firm fixed price terms typical of pharmaceutical procurement. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $1,059.72 to AmerisourceBergen Drug Corp for the supply of Humalog 100 Unit/ML KwikPen 3ML insulin pens. This firm fixed-price delivery order, issued on August 25, 2025, with an ultimate completion date of August 26, 2025, represents a competitive award with no set-aside designation. The contract will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $1,283.00 to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Humalog 200 Unit/mL KwikPen 3mL insulin pens. This is a firm fixed-price delivery order with no set-aside designation, completed competitively through open competition. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 19, 2025. This award represents a...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,545.54 for Humalog 100 Unit/ML KwikPen 3ML insulin pens, with an ultimate completion date of August 25, 2025. This non-set-aside contract utilizes firm fixed pricing and represents a competitive award to the pharmaceutical distributor. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on September 4, 2025, for the supply of Humalog Jr 100 Unit/mL KwikPen 3mL insulin pens, valued at $4,020.86. This is a firm fixed-price delivery order with an ultimate completion date of September 5, 2025, and will be performed at the vendor's location in Conshohocken, Pennsylvania. The contract was competitively awarded without any set-aside designation, reflecting AmerisourceBergen's demonstrated...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $1,815.02 to supply Humalog 100 Unit/mL KwikPen 3 mL insulin pens. This is a firm fixed-price delivery order with no set-aside designation, completed on August 1, 2025, and fulfills pharmaceutical supply requirements for federal medical procurement. The award leverages AmerisourceBergen's established capacity as a critical pharmaceutical distributor within the federal supply chain, particularly for...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,449.12 to AmerisourceBergen Drug Corp for Humalog 200 Unit/ML KwikPen 3ML insulin pens. This is a firm fixed price, non-competitive delivery order completed on August 28, 2025, with the pharmaceutical distributor fulfilling the order from its corporate office in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical procurement supporting federal medical supply needs. This delivery order operates under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $1,227.19 to supply Humalog 100 Unit/mL KwikPen 3mL insulin pens. This contract, which was not set-aside for small business, was executed on August 14, 2025, with an ultimate completion date of August 15, 2025. The pharmaceutical product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters. The delivery order...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB25FNABTDelivery Order
The Defense Logistics Agency has awarded a delivery order valued at $1,685.41 to AmerisourceBergen Drug Corp for the supply of Humalog 100 Unit/mL KwikPen 3mL insulin pens. The contract is a firm fixed price delivery order with no set-aside designation, awarded on September 10, 2025, with an ultimate completion date of September 11, 2025. Performance will be executed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract action under AmerisourceBergen Drug Corp's existing pharmaceutical supply relationship with the Defense Logistics Agency. This award falls within AmerisourceBergen Drug Corp's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The prime indefinite delivery vehicle enables the contractor to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. As a major pharmaceutical distributor and critical vendor for federal medical procurement, AmerisourceBergen Drug Corp serves the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through competitively awarded contracts covering brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 9/10/25 |